[go: up one dir, main page]

IN2014MU00626A - - Google Patents

Download PDF

Info

Publication number
IN2014MU00626A
IN2014MU00626A IN626MU2014A IN2014MU00626A IN 2014MU00626 A IN2014MU00626 A IN 2014MU00626A IN 626MU2014 A IN626MU2014 A IN 626MU2014A IN 2014MU00626 A IN2014MU00626 A IN 2014MU00626A
Authority
IN
India
Prior art keywords
propanediol
hydrates
provides
dapagliflozin
formula
Prior art date
Application number
Other languages
English (en)
Inventor
Shri Prakash Dhar Dwivedi
Brij Khera
Jagdish Maganlal Patel
Original Assignee
Cadila Healthcare Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cadila Healthcare Ltd filed Critical Cadila Healthcare Ltd
Priority to IN626MU2014 priority Critical patent/IN2014MU00626A/en
Priority to US14/626,341 priority patent/US20150307540A1/en
Publication of IN2014MU00626A publication Critical patent/IN2014MU00626A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C31/00—Saturated compounds having hydroxy or O-metal groups bound to acyclic carbon atoms
    • C07C31/18—Polyhydroxylic acyclic alcohols
    • C07C31/20—Dihydroxylic alcohols
    • C07C31/205—1,3-Propanediol; 1,2-Propanediol
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00—Processes for the preparation of sugar derivatives
    • C07H1/06—Separation; Purification
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H7/00—Compounds containing non-saccharide radicals linked to saccharide radicals by a carbon-to-carbon bond
    • C07H7/04—Carbocyclic radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IN626MU2014 2014-02-21 2014-02-21 IN2014MU00626A (ja)

Priority Applications (2)

Application Number Priority Date Filing Date Title
IN626MU2014 IN2014MU00626A (ja) 2014-02-21 2014-02-21
US14/626,341 US20150307540A1 (en) 2014-02-21 2015-02-19 Amorphous form of dapagliflozin 1,2-propanediol

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN626MU2014 IN2014MU00626A (ja) 2014-02-21 2014-02-21

Publications (1)

Publication Number Publication Date
IN2014MU00626A true IN2014MU00626A (ja) 2015-09-25

Family

ID=54334132

Family Applications (1)

Application Number Title Priority Date Filing Date
IN626MU2014 IN2014MU00626A (ja) 2014-02-21 2014-02-21

Country Status (2)

Country Link
US (1) US20150307540A1 (ja)
IN (1) IN2014MU00626A (ja)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3349762B1 (en) 2015-09-15 2021-08-25 Laurus Labs Limited Co-crystals of sglt2 inhibitors, process for their preparation and pharmaceutical compositions thereof
US11020412B2 (en) 2017-03-16 2021-06-01 Inventia Healthcare Limited Pharmaceutical composition comprising dapagliflozin
TR201918102A1 (tr) * 2019-11-20 2021-07-26 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Bi̇r polar çözücüden i̇zole edi̇lmi̇ş amorf dapagli̇flozi̇n i̇çeren kati farmasöti̇k kompozi̇syon
WO2021176096A1 (en) 2020-03-05 2021-09-10 Krka, D.D., Novo Mesto Pharmaceutical composition comprising sglt2 inhibitor

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6515117B2 (en) * 1999-10-12 2003-02-04 Bristol-Myers Squibb Company C-aryl glucoside SGLT2 inhibitors and method

Also Published As

Publication number Publication date
US20150307540A1 (en) 2015-10-29

Similar Documents

Publication Publication Date Title
PH12018502535B1 (en) Substituted carbonucleoside derivatives useful as anticancer agents
MX2020005213A (es) Inhibidores de proteina cinasa 2 activada por proteina cinasa activada por mitogeno (mk2) y sus usos.
PH12016501966A1 (en) Compounds and compositions as toll-like receptor 7 agonists
MX2017008518A (es) Compuestos de isoquinolina para el tratamiento de virus de inmunodeficiencia humana (vih).
TW201613911A (en) Heterocyclic compounds and uses thereof
TW201613886A (en) 3-amino-1,5,6,7-tetrahydro-4h-indol-4-ones
TW201613859A (en) Analogs of PRIDOPIDINE, their preparation and use
PH12016501192A1 (en) Tetrahydropyridopyrazines modulators of gpr6
MX2018016038A (es) Compuestos y metodos para modular la funcion del acido ribonucleico (arn).
MX2017008520A (es) Compuestos de pirimidina fusionada para el tratamiento del virus de inmunodeficiencia humana (vih).
NZ724878A (en) Compounds and compositions as toll-like receptor 7 agonists
PH12017500660A1 (en) Novel compositions, uses and methods for making them
MY189454A (en) 6-hydroxy-4-oxo-1,4-dihydropyrimidine-5-carboxamides as apj agonists
SG10201908839QA (en) 2,4-dihydroxy-nicotinamides as apj agonists
MX2018004674A (es) Moduladores de interacción de sestrina-gator2 y sus usos.
NZ730250A (en) 1-alkyl-6-oxo-1,6-dihydropyridin-3-yl compounds and use as sgrm modulators
TN2018000057A1 (en) Compounds useful for inhibiting ror-gamma-t.
EP4339192A3 (en) Compounds and compositions for the treatment of cancer
PH12017500459A1 (en) Azetidinyloxyphenylpyrrolidine compounds
PH12016501613A1 (en) Pyrazines modulators of gpr6
IN2014CH00840A (ja)
IN2014MU00626A (ja)
PH12017502148A1 (en) Pharmaceutical compositions and use thereof
UA117524C2 (uk) Стимулятори рослин, їх застосування та спосіб стимуляції рослин
MX2020004221A (es) Composicion farmaceutica que comprende derivado de quinolina.